Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition? (dgac154, 2022)
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM(2022)